{"name":"Innate Immunotherapeutics","slug":"innate-immunotherapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9EckM1ZG13bndvUTBSODJUR0liQk9NSFktYVZnbjdkS200bjVWWW94N29pM09aU3dtN0dkaFhmLTJTa2ZSS0xCYnZ6VnlNU3lBeU1WNElPcm1NUElGN2taVlA0cmFIVXRwaUZFdXBKdW1kVGJWemRXQVMxUHg?oc=5","date":"2025-12-30","type":"pipeline","source":"Global Growth Insights","summary":"Who Are the Top 19 NK Cell Therapy Companies Globally? - Global Growth Insights","headline":"Who Are the Top 19 NK Cell Therapy Companies Globally?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxOdnhmb3hDMjc5MTMydU5sdl9iWGJmSU9WSmRWb2ZVQk1zT1ktWm9oQnU4VHFIdXZsalhkajUzd1l6LTY5ckdCVFE2WldVcjF0Zi12Q2xxMkFrRVUydk9XMjdIMGdGWXdHRDkySlpuWlJPdk1ZckdQVmxmdGxZLTREZHU3RGIxZFU5OUJ0cjMzaHlwYTdKQ1hZ?oc=5","date":"2024-03-12","type":"pipeline","source":"BioWorld News","summary":"Onko-innate seeks targets thought to be undruggable - BioWorld News","headline":"Onko-innate seeks targets thought to be undruggable","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxORFByX2NaTnBzVjBTakVZdDJUTy1Wd3ZkLUhyY1hlQ0RfSXl0Mkw3d1BmMDZZSlJZcEt2VURoeWgyZ0RQczFFYUNEanA5cDhXTERIR0M1UU5TQUNMZFZ2VUpOM0pKTFZVN2VfMk1YUGU4ODh4NWVJd3FpeUMtVUpfTTBESkdocDRRWnpreFFkSXk?oc=5","date":"2024-02-20","type":"regulatory","source":"Frontiers","summary":"Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker? - Frontiers","headline":"Case Report: Response to Immunotherapy, Can Radiotherapy Be a Troublemaker?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNZVF6eG44NFBHcDBVTEVXcVZFaElRcEN6TzJiR2c0YmpGdkNvM0hadzBBMlZodjN0SVFJNkJLX1RMenZKWW1FRmJUQnNFSktQMC1QanNjZGFTbkFJa3Jpb0E2NnRFMHAtSHJnTWJpaDhQT1lZOGsxNVZuREhyTmJ4V3JScWJiM0dDM0E0X3BuZHdhLUpBT0Znd3hlX1FpdjF4X18xb2FmS3VHdw?oc=5","date":"2020-09-15","type":"pipeline","source":"Ventus Therapeutics","summary":"Ventus Therapeutics Appoints Industry Veteran, Steven James, to Board of Directors - Ventus Therapeutics","headline":"Ventus Therapeutics Appoints Industry Veteran, Steven James, to Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPWk9MZDZObVBtaGlrNmdOaVNPODNBZjJEN3FoYXlTcW52WVZBbXA1TGFXTV96Y0o3dkFkdVJXbzlIamV5STI1dlRJQkI1MU1RV2ZkTk40T3V0eU5CbE9KOEpKZFJrS1R6U05zek5UQmJKRTdPTU93TWdSQTl4dS1XZ0IwSUtHWUE?oc=5","date":"2018-08-11","type":"deal","source":"The New York Times","summary":"A Congressman, a Financial Deal and an Intricate Web of Conflicts (Published 2018) - The New York Times","headline":"A Congressman, a Financial Deal and an Intricate Web of Conflicts (Published 2018)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQOTRGVXJ3T2FwZkhsT3pNY1REaGhPSFRQWU5FQUt1MGcyTFJNamczVm52ZEJEMjhYVnNxQUFaWXEwWmRwVm5GcWNMZUFEMnBWZDBETDBGTlBxMzZPanhIY0xHdENFV004R2RKNUlDN2dja0xKQjlTM3NTdHpEX250MlFvSm1TTlpObDFOcXlSWGFxakRxalhXVFJlWVNNTThGUVHSAacBQVVfeXFMTXc3dW03Y2FUbmQ5N1NLNlNHV3ZRZlhCWi1mZnFrOFdDTXJ3Qkk0T1c4c0xHUlVoX2c0eFk5X2ZGeUM0eHBFUXBRYTR5cngzd2RWRzd4UkhNVkNwdGVfQjJONHJvdXVJMVZxckRzZHQ3Zko1TFNtNzdYVFIxZDV2aDVfWnBrZzVuc1ZZdFBtUU9BRnllTmoxV1ZqdHBjT2NuY3R6QURjX0U?oc=5","date":"2018-08-09","type":"trial","source":"CNBC","summary":"GOP Rep. Chris Collins' son and son's fiancee bought drug company stock days before Collins warned about failed trial, the SEC alleges - CNBC","headline":"GOP Rep. Chris Collins' son and son's fiancee bought drug company stock days before Collins warned about failed trial, t","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPR2J6d19fU2lTVFV6dTJMajl2RE1EWkpxc2RkWk9LMVpDaWtlQ3hhbGMwQ1dxTnhVb04zNmRHdV9XZWFaTFZJUlI0M01XbWtCWUdvTFBYbGV0NjJ3MU9EdEZDOTFhZDFhQ1RyYU1Sb2x2c0ZSeDV2VDMyeHltTlRUeENoRDA0MVFENHBzUFBjS1BGNGpxTEtFU05MVQ?oc=5","date":"2018-08-08","type":"pipeline","source":"The Texas Tribune","summary":"2 Texas congressmen bought stock in company at center of insider trading case against New York congressman - The Texas Tribune","headline":"2 Texas congressmen bought stock in company at center of insider trading case against New York congressman","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE94MnlNQW1fQ0lySE1lUWEtbTFIcmRLRnpGWnd1X0pxa0l0Qm1CaWY4Y213bDZaMFRVdWlyMmdVZldWMWJhdHBNNEZ1Y3JRdExJY0dnNEZETGRhamtOUG96aUhvdDVIM0lOdTA3aExNNDE3QUozX1R1Vg?oc=5","date":"2017-06-28","type":"pipeline","source":"MassDevice","summary":"NY Rep. Collins loses millions on Innate flop - MassDevice","headline":"NY Rep. Collins loses millions on Innate flop","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNRnpPWXp1bERJM1FpMl9UeDU0Vlg2d1RQRV9SYmRyYkdUemx6OEtkbG1URzFRcU5XSTNMbWQwTzRMeEZndGRHMkE0N3BrN2FmdVg4REJxdnlDWnl0c1lBUWpDQlN3RzZJVTlyT010RjRPT2xWVmI0LTFtdkk3eU1Ub3NMc0xpZHJxWFB0ag?oc=5","date":"2017-06-27","type":"pipeline","source":"BioPharma Dive","summary":"Innate becomes the latest loser in MS - BioPharma Dive","headline":"Innate becomes the latest loser in MS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxPZFRtV28ya2V5VzdSLUdDaEkyVjNTVlJRY3paQV9RWW5JOV9XX1FtdmU5cldKWUNGQkE1Z3BSUGZrd2staE5PZ280cGF1TkkydG5jdkZWMk10THFGY3piZU1BaHdYSVlpUjl6SzlNVkI0b2VFTXJ5ZE5tYnI3S0tsWDlsVUYwZjZvdTRIdm81Rk9HMjlsaTNQOUJIZjc4ZTlUaVVqY0c3UGVpQlJabVhoWUF1dw?oc=5","date":"2017-06-27","type":"pipeline","source":"Bloomberg.com","summary":"GOP Lawmaker Loses $17 Million After Favorite Pharma Stock Plunges - Bloomberg.com","headline":"GOP Lawmaker Loses $17 Million After Favorite Pharma Stock Plunges","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNZFpBbU5TWTliWGlKTjNwOVNJOWtqME1DeVdwYlc2REk4T2NPNDRTbHFIbmNzVXhJMnFyZ1JYMENLMHB0U1JNNXByMXhTZEZTMjdFMW9VZ3dxZzNNckhVR0dNQU5ER3R3NGw2Y19GbWFZRFRjd0JqSVFWZkp0ZUdJbTBUbU1ZU1FOa0RTOGw5MmQ4d0V4RkdMUW12RXNMWVNUd3RoN3JOajk?oc=5","date":"2017-06-01","type":"pipeline","source":"propublica.org","summary":"Tom Price Bought Drug Stocks. Then He Pushed Pharma’s Agenda in Australia. - propublica.org","headline":"Tom Price Bought Drug Stocks. Then He Pushed Pharma’s Agenda in Australia.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE1vMkRkU29vc0wwN284eGtkMEZSLXVBSllmaTRIQUFUYnJrVEFyYV9Zem1SRnljcVJobVZXZDZrZm9XbEVuTkFqV1FJZVctcWY1akxYOFVSTlM0R3BIbGRQQnF4Q3dzVzEtUGZoTnl4dUdaR1NiLVNDd1B6QTA?oc=5","date":"2017-01-13","type":"deal","source":"statnews.com","summary":"Trump’s HHS nominee got a sweetheart deal from a foreign biotech firm - statnews.com","headline":"Trump’s HHS nominee got a sweetheart deal from a foreign biotech firm","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}